US regulators to measure conflicting peptides with the help of RFK Jr | Health Issues

The U.S. Food and Drug Administration has questioned this evidence because of its many claims for sleep, muscle growth, and anti-aging.

Peptides, a group of drugs that are widely marketed as medical treatments, have gained popularity in recent years, from niche bodybuilding and biohacking circles to now being promoted for everything from weight loss to longevity.

But as questions grow as to whether many of them are safe or work as advertised, regulators in the United States are set to decide whether some of them should be available through pharmacies.

The Pharmacy Compounding Advisory Committee of the US Food and Drug Administration (FDA) will meet on Thursday and Friday to decide whether these seven peptides can be made by licensed pharmacies for patients with prescriptions.

Peptides are short chains of amino acids that occur naturally in the body and help regulate many biological processes. Other peptide-based drugs, including GLP-1 weight loss drugs such as Ozempic and Wegovy, have become household names in recent years. But the seven peptides under review this week are a separate class of drugs marketed for different purposes.

They include BPC-157, TB-500 and KPV, which are recommended for uses including ulcerative colitis, the treatment of ulcers and tumors, and others that are marketed as solutions for obesity, migraines, chronic pain, insomnia and opioid withdrawal.

The review comes as peptides have been fronted by social media fans, the rise of internet beauty known as “looksmaxxing”, and repeated endorsements from. Health Secretary Robert F Kennedy Jrwho has said he has used them with “excellent results” and said restrictions have pushed consumers into the unregulated gray market.

These developments have concerned scientists at the FDA, who have repeatedly questioned the evidence for many peptides. In this week’s conference papers, the agency said there is little evidence to prove the safety or efficacy of the seven groups under review, citing insufficient human clinical trials and concerns about their quality, stability and consistency.

But despite the concerns, demand continues to grow. These drugs are marketed through health clinics and promote everything from muscle building and weight loss to anti aging. Reddit forums dedicated to peptide use have become a place where thousands of users compare vendors, discuss dosing and share their experiences.

Industry groups argue that the need is why the FDA should make it easier for licensed pharmacies to mix peptides, thereby enabling greater drug monitoring and higher standards.

But even the composition of the advisory committee itself is controversial.

According to AP, seven of the 14 members of the group have relationships with businesses or hospitals involved in peptide therapy. They include doctors who run clinics selling peptide injections and promote them on social media, as well as pharmacist and Tennessee State Senator Bobby Harshbarger, whose family owns a pharmacy that sells compounded drugs. His mother, Republican US Congresswoman Diana Harshbarger, urged Kennedy last year to loosen FDA restrictions on peptides.

The Department of Health and Human Services has defended the group, saying that each member reviewed the requirements of the FDA’s advisory committees and that anyone who failed to meet federal requirements was removed.

Although the group’s recommendations are not binding, they are expected to help make the FDA’s final decision.